Marathon Pharmaceuticals, LLC Names Babar Ghias Chief Financial Officer

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals, LLC, a biopharmaceutical company focused on developing treatments for rare diseases and neurological disorders, today named Babar Ghias its chief financial officer.

In his new role, Ghias will have primary day-to-day responsibility for planning, implementing, managing and controlling all financial-related activities of the company.